Roadmap for CMs

Roadmap for CMs

This document has been prepared to serve as guidance to stakeholders regarding the regulation pathway of Category D medicines ( complementary medicines registration. It represe ) for which claims of safety, quality and efficacy and which may be called up for nts the South African Health Products Regulatory Authority’s current thinking on the appropriate assurance of safety, quality and efficacy of CMs and the intention of the Authority over the described period of time

2021 Dec

Download latest version
File Type: pdf
Category: Guideline
Unit: Complementary Medicines